Array Biopharma Inc news

   Watch this stock
Showing stories 1 - 10 of about 68   

Articles published

ARRY 3.79 -0.05 (-1.30%)
price chart
Traders Watch List - Avanir Pharmaceuticals Inc (AVNR), Array Biopharma Inc ...
Las Vegas, NV - April 19, 2013 - (Tech Sonian) �Avanir Pharmaceuticals Inc (NASDAQ:AVNR) recently declared that the U.S. Food and Drug Administration (FDA) has accepted the company's New Drug Application (NDA) of AVP-825, its innovative Breath ...
Biotech Stocks Analysis -- Research on Array BioPharma, ACADIA Pharma ...
Array BioPharma Inc.'s stock lost 3.43% on Wednesday, closing at $4.79, after oscillating between $4.75 and $5.01. A total of 1.63 million shares were traded, which is above its three months average volume of 1.35 million.
Array Biopharma Inc (NASDAQ:ARRY) Lull, Despite Asthma Phase 2 Trial Results
Dallas, Texas 04/09/2014 (FINANCIALSTRENDS) - Array Biopharma Inc (NASDAQ:ARRY) unlike some of the other stocks in this sector, had marginally better results to show for this week.
Watch List � Petroquest Energy (NYSE:PQ), Array Biopharma Inc (NASDAQ ...  Techsonian (press release)
Related articles »  
Heavily Traded Stocks: Array Biopharma Inc (ARRY), Affymetrix, Inc. (AFFX ...
Manhattan, NY- April 18, 2014 - (Techsonian) - Array Biopharma Inc (NASDAQ:ARRY) focuses on the discovery, development, and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases mainly in North ...
Related articles »  
Watch List �Rambus Inc.(NASDAQ:RMBS), Array Biopharma Inc (NASDAQ ...
Array Biopharma Inc (NASDAQ:ARRY), released that it's Q4 2013 and full-year 2013 financial results. For Q4 2013, net product revenues totaled $74.8 million compared to $85.5 million in Q4 2012.
Related articles »  
Watch List: Array Biopharma Inc (ARRY), Orexigen Therapeutics, Inc. (OREX), Hi ...
Las Vegas, NV - April 11, 2014� (TechSonian) �Array Biopharma Inc (ARRY) focuses on the discovery, development, and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases mainly in North America, ...
Related articles »  
Stocks in Focus: Array Biopharma Inc (NASDAQ:ARRY), Blackhawk Network ...
Las Vegas, NV - April 16, 2014 - (TechSonian) - Array Biopharma Inc (NASDAQ:ARRY) a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients afflicted with cancer and ...
NASDAQ losers: Chelsea Therapeutics International (NASDAQ:CHTP ...  Tech News
Related articles »  
Biotech Stocks Touched New Lows: Onconova Therapeutics Inc (NASDAQ ...
Investors in Array BioPharma Inc. (NASDAQ:ARRY) saw new options begin trading this week, for the May 17th expiration. It was looked up and down the ARRY options chain for the new May 17th contracts.
Related articles »  
NASDAQ New Lows: Array Biopharma Inc (NASDAQ:ARRY), Momenta ...
Array Biopharma Inc (NASDAQ:ARRY) issued a press release announcing that Array reported full results from a randomized Phase 2 trial of ARRY-502 in patients with mild to moderate Th2-Driven Asthma at the 2014 American Academy Of Allergy, Asthma ...
Traders Watch List - Array Biopharma Inc (NASDAQ:ARRY), McEwen Mining Inc ...  Techsonian (press release)
Related articles »  
Stocks to Keep Your Eyes on: Sequenom, Inc. (SQNM), Array Biopharma Inc ...
Sequenom, Inc. (NASDAQ:SQNM) gained +2.81% percent with 116.30 million shares crossing the floor of the Exchange. The typical daily volume of this stock is about 1.22 million shares.
Related articles »